Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
R Soc Open Sci ; 11(5): 240088, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-39076798

RESUMEN

Campylobacter concisus is an opportunistic bacterial pathogen linked with a range of human diseases. The objective of this study was to investigate the viable but nonculturable (VBNC) state of the bacterium. To induce the VBNC state, C. concisus cells were maintained in sterilized phosphate-buffered saline at 4°C for three weeks. The VBNC cells were monitored using quantitative analysis by propidium monoazide (PMAxx) coupled with quantitative real-time PCR (PMAxx-qPCR), targeting the DNA gyrase subunit B gene. The results demonstrated that C. concisus ATCC 51562 entered the VBNC state in 15 days, while ATCC 51561 entered the VBNC state in 9 days. The viable cell counts, assessed by PMAxx-qPCR, consistently remained close to the initial level of 107 CFU ml-1, indicating a substantial portion of the cell population had entered the VBNC state. Notably, morphological analysis revealed that the VBNC cells became coccoid and significantly smaller. The cells could be resuscitated through a temperature increase in the presence of a highly nutritious growth medium. In conclusion, under environmental stress, most C. concisus cells converted to the VBNC state. The VBNC state of C. concisus may be important for its environmental survival and spread, and the presence of VBNC forms should be considered in environmental and clinical monitoring.

2.
Microorganisms ; 12(1)2023 Dec 27.
Artículo en Inglés | MEDLINE | ID: mdl-38257873

RESUMEN

Campylobacter concisus is a bacterium that inhabits human oral cavities and is an emerging intestinal tract pathogen known to be a biofilm producer and one of the bacterial species found in dental plaque. In this study, biofilms of oral and intestinal C. concisus isolates were phenotypically characterized. The role of the luxS gene, which is linked to the regulation of biofilm formation in other pathogens, was assessed in relation to the pathogenic potential of this bacterium. Biofilm formation capacity was assessed using phenotypic assays. Oral strains were shown to be the highest producers. A luxS mutant was created by inserting a kanamycin cassette within the luxS gene of the highest biofilm-forming isolate. The loss of the polar flagellum was observed with scanning and transmission electron microscopy (SEM and TEM). Furthermore, the luxS mutant exhibited a significant reduction (p < 0.05) in biofilm formation, motility, and its expression of flaB, in addition to the capability to invade intestinal epithelial cells, compared to the parental strain. The study concluded that C. concisus oral isolates are significantly higher biofilm producers than the intestinal isolates and that LuxS plays a role in biofilm formation, invasion, and motility in this bacterium.

3.
Food Chem ; 381: 132272, 2022 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-35123227

RESUMEN

This work examines the relationship between microstructural properties of hot-moulded chitosan networks, crosslinked with trisodium phosphate, and diffusive behaviour from these networks. Analysis through infrared spectroscopy (FTIR) confirmed successful crosslinking of the polymer chains and bioactive entrapment, while X-ray diffraction (WAXD) and dynamic oscillation in-shear elucidated the higher order structural properties of each matrix, as they transitioned from solutions to amorphous gels to semi-crystalline matrices. The picture of molecular motion observed in these systems and consequent application of the Flory-Rehner theory further indicated that different extents of chitosan crosslinking yielded a distinct water infusion functionality seen in the levels of swelling. Diffusion of caffeine from these delivery vehicles showed that network structural properties (governed by crosslinker concentration) had a significant effect on the release kinetics of the entrapped bioactive. The relationship between network mesh characteristics and diffusion properties were further confirmed by correlating caffeine release rates and molecular pore size.


Asunto(s)
Quitosano , Cafeína , Quitosano/química , Reactivos de Enlaces Cruzados/química , Difusión , Cinética , Fosfatos , Espectroscopía Infrarroja por Transformada de Fourier , Difracción de Rayos X
4.
Antibiotics (Basel) ; 10(6)2021 Jun 11.
Artículo en Inglés | MEDLINE | ID: mdl-34208266

RESUMEN

Giardiasis is a major diarrheal disease affecting approximately 2.5 million children annually in developing countries. Several studies have reported the resistance of Giardia lamblia (G. lamblia) to multiple drugs. Therefore, identifying an effective drug for giardiasis is a necessity. This study examined the antiparasitic effect of Punica granatum (pomegranate) and evaluated its therapeutic efficacy in rats infected with G. lamblia. In vitro study showed high efficacy of pomegranate peel ethanolic extract in killing G. lamblia cysts as demonstrated by eosin vital staining. We showed that treating infected rats with pomegranate extract resulted in a marked reduction in the mean number of G. lamblia cysts and trophozoites in feces and intestine respectively. Interestingly, the number of G. lamblia trophozoites and cysts were significantly lower in the pomegranate extract-treated group compared to the metronidazole-positive control group. Moreover, pomegranate extract treatment significantly induced nitric oxide (NO) and reduced serum IL-6 and TNF-α, compared to infected untreated rats. Histological and scanning electron microscopy (SEM) examination of the jejunum and duodenum of pomegranate extract-treated animals confirmed the antiparasitic effect of the extract, and demonstrated the restoration of villi structure with reduction of villi atrophy, decreased infiltration of lymphocytes, and protection of intestinal cells from apoptotic cell death. In conclusion, our data show that the pomegranate peel extract is effective in controlling G. lamblia infections, which suggests that it could be a viable treatment option for giardiasis.

5.
Int J Mol Sci ; 22(5)2021 Mar 06.
Artículo en Inglés | MEDLINE | ID: mdl-33800956

RESUMEN

Crosslinking of hydroxypropyl methyl cellulose (HPMC) and acrylic acid (AAc) was carried out at various compositions to develop a high-solid matrix with variable glass transition properties. The matrix was synthesized by the copolymerisation of two monomers, AAc and N,N'-methylenebisacrylamide (MBA) and their grafting onto HMPC. Potassium persulfate (K2S2O8) was used to initiate the free radical polymerization reaction and tetramethylethylenediamine (TEMED) to accelerate radical polymerisation. Structural properties of the network were investigated with Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), modulated differential scanning calorimetry (MDSC), small-deformation dynamic oscillation in-shear, thermogravimetric analysis (TGA) and scanning electron microscopy (SEM). The results show the formation of a cohesive macromolecular entity that is highly amorphous. There is a considerable manipulation of the rheological and calorimetric glass transition temperatures as a function of the amount of added acrylic acid, which is followed upon heating by an extensive rubbery plateau. Complementary TGA work demonstrates that the initial composition of all the HPMC-AAc networks is maintained up to 200 °C, an outcome that bodes well for applications of targeted bioactive compound delivery.


Asunto(s)
Acrilamidas/química , Derivados de la Hipromelosa/química , Acrilatos/química , Rastreo Diferencial de Calorimetría , Vidrio , Ensayo de Materiales , Microscopía Electrónica de Rastreo , Polimerizacion , Espectroscopía Infrarroja por Transformada de Fourier , Termogravimetría , Vitrificación , Difracción de Rayos X
6.
Syst Appl Microbiol ; 44(3): 126187, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33677170

RESUMEN

Although at least two genetically distinct groups, or genomospecies, have been well documented for Campylobacter concisus, no phenotype has yet been identified for their differentiation and thus formal description as separate species. C. concisus has been isolated from a variety of sites in the human body, including saliva and stool samples from both healthy and diarrhoeic individuals. We evaluated the ability of a range of whole genome-based tools to distinguish between the two C. concisus genomospecies (GS) using a collection of 190 C. concisus genomes. Nine genomes from related Campylobacter species were included in some analyses to provide context. Analyses incorporating sequence analysis of multiple ribosomal genes generated similar levels of C. concisus GS discrimination as genome-wide comparisons. The C. concisus genomes formed two groups; GS1 represented by ATCC 33237T and GS2 by CCUG 19995. The two C. concisus GS were separated from the nine genomes of related species. GS1 and GS2 also differed in G+C content with medians of 37.56% and 39.51%, respectively. The groups are consistent with previously established GS and are supported by DNA reassociation results. Average Nucleotide Identity using MUMmer (ANIm) and Genome BLAST Distance Phylogeny generated in silico DNA-DNA hybridisation (isDDH) (against ATCC 33237T and CCUG 19995), plus G+C content provides cluster-independent GS discrimination suitable for routine use. Pan-genomic analysis identified genes specific to GS1 and GS2. WGS data and genomic species identification methods support the existence of two GS within C. concisus. These data provide genome-level metrics for strain identification to genomospecies level.


Asunto(s)
Campylobacter , Genoma Bacteriano , Filogenia , Composición de Base , Campylobacter/clasificación , Campylobacter/genética , Genómica , Hibridación de Ácido Nucleico
7.
Eur J Pharm Biopharm ; 151: 181-188, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32315699

RESUMEN

The increasing prevalence of multidrug resistant bacteria has warranted the search for new antimicrobial agents as existing antibiotics lose their potency. Among these, bacteriophage therapy, as well as the administration of specific bacteriolysis agents, i.e., lytic enzymes, have emerged as attractive alternatives. Nebulizers offer the possibility for delivering these therapeutics directly to the lung, which is particularly advantageous as a non-invasive and direct route to treat bacterial lung infections. Nevertheless, nebulizers can often result in significant degradation of the bacteriophage or protein, both structurally and functionally, due to the large stresses the aerosolization process imposes on these entities. In this work, we assess the capability of a novel low-cost and portable hybrid surface and bulk acoustic wave platform (HYDRA) to nebulize a Myoviridae bacteriophage (phage K) and lytic enzyme (lysostaphin) that specifically targets Staphylococcus aureus. Besides its efficiency in producing phage or protein-laden aerosols within the 1-5 µm respirable range for optimum delivery to the lower respiratory tract where lung infections commonly take place, we observe that the HYDRA platform-owing to the efficiency of driving the aerosolization process at relatively low powers and high frequencies (approximately 10 MHz)-does not result in appreciable denaturation of the phages or proteins, such that the loss of antimicrobial activity following nebulization is minimized. Specifically, a low (0.1 log10 (pfu/ml)) titer loss was obtained with the phages, resulting in a high viable respirable fraction of approximately 90%. Similarly, minimal loss of antimicrobial activity was obtained with lysostaphin upon nebulization wherein its minimum inhibitory concentration (0.5 µg/ml) remained unaltered as compared with the non-nebulized control. These results therefore demonstrate the potential of the HYDRA nebulization platform as a promising strategy for pulmonary administration of alternative antimicrobial agents to antibiotics for the treatment of lung diseases caused by pathogenic bacteria.


Asunto(s)
Antibacterianos/administración & dosificación , Antibacterianos/química , Pulmón/efectos de los fármacos , Staphylococcus aureus/efectos de los fármacos , Acústica , Administración por Inhalación , Aerosoles/administración & dosificación , Aerosoles/química , Bacteriólisis/efectos de los fármacos , Bacteriófagos/efectos de los fármacos , Pruebas de Sensibilidad Microbiana/métodos , Myoviridae/efectos de los fármacos , Nebulizadores y Vaporizadores , Infecciones Estafilocócicas/tratamiento farmacológico
8.
Future Med Chem ; 4(12): 1553-65, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22917245

RESUMEN

BACKGROUND: Resonant recognition model-myxoma virus (RRM-MV), a bioactive peptide analogue for myxoma virus MV-T5 protein, was computationally designed by the RRM. In this study, the anticancer effects of RRM-MV were assessed in vitro against four negative control peptides on human skin cancer and normal cells. RESULTS & DISCUSSION: The effects of RRM-MV versus negative control peptides on cells were evaluated by quantitative and qualitative assays. The RRM-MV treatment was able to induce cell death in cancer cells without triggering similar effects on normal cells. However, the negative control peptides produced no toxic effects on skin cancer and normal cells. No effects on human erythrocytes were detected when treated with all peptides. CONCLUSION: It is suggested that the RRM can be applied to design therapeutic anticancer peptides.


Asunto(s)
Péptidos/toxicidad , Secuencia de Aminoácidos , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Fibroblastos/enzimología , Humanos , L-Lactato Deshidrogenasa/metabolismo , Microscopía Confocal , Datos de Secuencia Molecular , Myxoma virus/metabolismo , Péptidos/química , Neoplasias Cutáneas/enzimología , Neoplasias Cutáneas/patología , Proteínas Virales/química
9.
J Biomed Sci ; 19: 65, 2012 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-22805371

RESUMEN

BACKGROUND: Cancer is an international health problem, and the search for effective treatments is still in progress. Peptide therapy is focused on the development of short peptides with strong tumoricidal activity and low toxicity. In this study, we investigated the efficacy of a myxoma virus peptide analogue (RRM-MV) as a candidate for skin cancer therapy. RRM-MV was designed using the Resonant Recognition Model (RRM) and its effect was examined on human skin cancer and normal human skin cells in vitro. METHODS: Cell cultures were treated with various concentrations of the peptides at different incubation intervals. Cellular morphological changes (apoptosis and necrosis) were evaluated using confocal laser scanning microscopy. The cytotoxic effects of RRM-MV on human skin cancer and normal human skin cells were quantitatively determined by cytotoxicity and cell viability assays. The effect on human erythrocytes was also determined using quantitative hemolysis assay. DNA fragmentation assay was performed to detect early apoptotic events in treated cancer cells. Furthermore, to investigate the possible cell signalling pathway targeted by the peptides treatment, the levels of p-Akt expression in skin cancer and normal cells were detected by immunoblotting. RESULTS: Our results indicate that RRM-MV has a dose-dependent toxic effect on cancer cells only up to 18 h. The immunoblotting results indicated that the RRM-MV slightly increased p-Akt expression in melanoma and carcinoma cells, but did not seem to affect p-Akt expression in normal skin cells. CONCLUSIONS: RRM-MV targets and lethally harms cancer cells and leaves normal cells unharmed. It is able to reduce the cancer cell viability, disrupting the LDH activity in cancer cells and can significantly affect cancer progression. Further investigation into other cell signalling pathways is needed in the process leading to the in vivo testing of this peptide to prove its safety as a possible effective treatment for skin cancer.


Asunto(s)
Carcinoma de Células Escamosas , Melanoma , Péptidos , Neoplasias Cutáneas , Apoptosis/efectos de los fármacos , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/terapia , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Fragmentación del ADN/efectos de los fármacos , Humanos , Técnicas In Vitro , Melanoma/genética , Melanoma/terapia , Myxoma virus/química , Necrosis , Péptidos/administración & dosificación , Péptidos/química , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal/efectos de los fármacos , Neoplasias Cutáneas/genética , Neoplasias Cutáneas/terapia
10.
PLoS One ; 6(9): e24809, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21949758

RESUMEN

BACKGROUND: The Resonant Recognition Model (RRM) is a physico-mathematical model that interprets protein sequence linear information using digital signal processing methods. In this study the RRM concept was employed for structure-function analysis of myxoma virus (MV) proteins and the design of a short bioactive therapeutic peptide with MV-like antitumor/cytotoxic activity. METHODOLOGY/PRINCIPAL FINDINGS: The analogue RRM-MV was designed by RRM as a linear 18 aa 2.3 kDa peptide. The biological activity of this computationally designed peptide analogue against cancer and normal cell lines was investigated. The cellular cytotoxicity effects were confirmed by confocal immunofluorescence microscopy, by measuring the levels of cytoplasmic lactate dehydrogenase (LDH) and by Prestoblue cell viability assay for up to 72 hours in peptide treated and non-treated cell cultures. Our results revealed that RRM-MV induced a significant dose and time-dependent cytotoxic effect on murine and human cancer cell lines. Yet, when normal murine cell lines were similarly treated with RRM-MV, no cytotoxic effects were observed. Furthermore, the non-bioactive RRM designed peptide RRM-C produced negligible cytotoxic effects on these cancer and normal cell lines when used at similar concentrations. The presence/absence of phosphorylated Akt activity in B16F0 mouse melanoma cells was assessed to indicate the possible apoptosis signalling pathway that could be affected by the peptide treatment. So far, Akt activity did not seem to be significantly affected by RRM-MV as is the case for the original viral protein. CONCLUSIONS/SIGNIFICANCE: Our findings indicate the successful application of the RRM concept to design a bioactive peptide analogue (RRM-MV) with cytotoxic effects on tumor cells only. This 2.345 kDa peptide analogue to a 49 kDa viral protein may be suitable to be developed as a potential cancer therapeutic. These results also open a new direction to the rational design of therapeutic agents for future cancer treatment.


Asunto(s)
Myxoma virus/química , Neoplasias/patología , Péptidos/farmacología , Animales , Anexina A5/metabolismo , Apoptosis/efectos de los fármacos , Muerte Celular/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Biología Computacional , Técnica del Anticuerpo Fluorescente , Humanos , Ratones , Microscopía Confocal , Modelos Moleculares , Myxoma virus/efectos de los fármacos , Fosforilación/efectos de los fármacos , Propidio/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Proteínas Virales/química , Proteínas Virales/farmacología
11.
Ann Clin Microbiol Antimicrob ; 9: 16, 2010 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-20504376

RESUMEN

BACKGROUND: Coagulase-negative staphylococci are major causes of bloodstream infections in very low birth weight babies cared for in Neonatal Intensive Care Units. The virulence of these bacteria is mainly due to their ability to form biofilms on indwelling medical devices. Biofilm-related infections often fail to respond to antibiotic chemotherapy guided by conventional antibiotic susceptibility tests. METHODS: Coagulase-negative staphylococcal blood culture isolates were grown in different phases relevant to biofilm formation: planktonic cells at mid-log phase, planktonic cells at stationary phase, adherent monolayers and mature biofilms and their susceptibilities to conventional antibiotics were assessed. The effects of oxacillin, gentamicin, and vancomycin on preformed biofilms, at the highest achievable serum concentrations were examined. Epifluorescence microscopy and confocal laser scanning microscopy in combination with bacterial viability staining and polysaccharide staining were used to confirm the stimulatory effects of antibiotics on biofilms. RESULTS: Most coagulase-negative staphylococcal clinical isolates were resistant to penicillin G (100%), gentamicin (83.3%) and oxacillin (91.7%) and susceptible to vancomycin (100%), ciprofloxacin (100%), and rifampicin (79.2%). Bacteria grown as adherent monolayers showed similar susceptibilities to their planktonic counterparts at mid-log phase. Isolates in a biofilm growth mode were more resistant to antibiotics than both planktonic cultures at mid-log phase and adherent monolayers; however they were equally resistant or less resistant than planktonic cells at stationary phase. Moreover, for some cell-wall active antibiotics, concentrations higher than conventional MICs were required to prevent the establishment of planktonic cultures from biofilms. Finally, the biofilm-growth of two S. capitis isolates could be enhanced by oxacillin at the highest achievable serum concentration. CONCLUSION: We conclude that the resistance of coagulase-negative staphylococci to multiple antibiotics initially remain similar when the bacteria shift from a planktonic growth mode into an early attached mode, then increase significantly as the adherent mode further develops. Furthermore, preformed biofilms of some CoNS are enhanced by oxacillin in a dose-dependent manner.


Asunto(s)
Antibacterianos/farmacología , Bacteriemia/microbiología , Biopelículas/efectos de los fármacos , Recién Nacido de muy Bajo Peso , Infecciones Estafilocócicas/microbiología , Staphylococcus/efectos de los fármacos , Staphylococcus/fisiología , Biopelículas/crecimiento & desarrollo , Inhibidores de Crecimiento/farmacología , Humanos , Recién Nacido , Unidades de Cuidado Intensivo Neonatal , Péptidos y Proteínas de Señalización Intercelular/farmacología , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Microscopía Confocal , Microscopía Fluorescente/métodos , Polisacáridos Bacterianos/análisis , Coloración y Etiquetado/métodos , Staphylococcus/aislamiento & purificación
12.
J Antimicrob Chemother ; 65(7): 1405-11, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20430788

RESUMEN

OBJECTIVES: (i) To evaluate the role of the adherent growth mode and extracellular polymer substance build-up in biofilm resistance to antibiotics. (ii) To re-assess various mechanisms leading to biofilm resistance to antibiotics. METHODS: We compared the biofilm MICs, biofilm MBCs using the viable count method, biofilm MBCs based on broth recovery methods and minimum biofilm eradication concentrations (MBECs) of antistaphylococcal antibiotics for multilayer biofilms formed by 'biofilm-positive' S. epidermidis strains and monolayer biofilms formed by their 'biofilm-negative' mutants/variants. Bacterial densities and the quantity of persister cells in both multilayer and monolayer biofilms were assessed to evaluate their roles in biofilm resistance. RESULTS: Monolayer and multilayer biofilms presented similar susceptibilities to multiple antibiotics, based on biofilm MIC, broth recovery-based biofilm MBC and MBEC results. Multilayer biofilms demonstrated higher viable count-based MBCs than monolayer biofilms. Both monolayer and multilayer biofilms had very high bacterial densities of approximately 10(11-12) cfu/mL. Persister cells were found in both monolayer and multilayer biofilms, but not in planktonic cultures at log phase. The presence of persister cells in monolayer and multilayer biofilms appeared to be strain and antibiotic dependent. CONCLUSIONS: The adherent growth mode, rather than the ability to build up a typical multilayer biofilm structure, contributes to the high resistance of biofilms to antibiotics, and therefore might be the main virulence factor of coagulase-negative staphylococci (CoNS) with respect to antibiotic resistance. The presence of persister cells in CoNS biofilms plays an important role in antibiotic resistance. Growth at high bacterial densities is another significant factor in biofilm resistance.


Asunto(s)
Antibacterianos/farmacología , Adhesión Bacteriana , Biopelículas/efectos de los fármacos , Biopolímeros/metabolismo , Farmacorresistencia Bacteriana , Staphylococcus epidermidis/efectos de los fármacos , Staphylococcus epidermidis/fisiología , Proteínas Bacterianas , Biopelículas/crecimiento & desarrollo , Humanos , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Factores de Transcripción
13.
J Med Microbiol ; 58(Pt 4): 442-450, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19273639

RESUMEN

Coagulase-negative staphylococci (CoNS) are the main causative agents of bacteraemia in infants managed in neonatal intensive care units (NICUs). Intraluminal colonization of long-term central venous catheters by these bacteria and subsequent biofilm formation are the prerequisites of the bloodstream infections acquired in NICUs. The catheter lock technique has been used to treat catheter colonization; however, the optimum choice of antimicrobial agents and their corresponding concentrations and exposure times have not been determined. The effectiveness of catheter lock solutions (CLSs) was assessed by determining the minimal biofilm eradication concentration of antimicrobial agents against CoNS biofilms. Five conventional antibiotics (oxacillin, gentamicin, vancomycin, ciprofloxacin and rifampicin) alone or in combination, as well as ethanol, were evaluated. Ethanol was found to be superior to all of these conventional antibiotics when used as a CLS. A time-kill study and confocal laser scanning microscopy revealed that exposure to 40 % ethanol for 1 h was sufficient to kill CoNS biofilm cells. To our knowledge, this is the first in vitro study to provide solid evidence to support the rationale of using ethanol at low concentrations for a short time as a CLS, instead of using conventional antibiotics at high concentrations for a long period to treat catheter-related bloodstream infections.


Asunto(s)
Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Etanol/farmacología , Staphylococcus/efectos de los fármacos , Staphylococcus/enzimología , Antibacterianos/administración & dosificación , Catéteres de Permanencia/microbiología , Quimioterapia Combinada , Etanol/administración & dosificación , Staphylococcus/clasificación , Factores de Tiempo
14.
FEMS Immunol Med Microbiol ; 54(2): 224-35, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18754784

RESUMEN

Campylobacter concisus is an opportunistic pathogen commonly found in the human oral cavity. It has also been isolated from clinical sources including gastroenteritis cases. Both secreted and cell-associated hemolytic activities were detected in C. concisus strains isolated from children with gastroenteritis. The secreted hemolytic activity of C. concisus strains was labile and was detected in variable levels from fresh-culture filtrates only. In addition, another secreted hemolysin/cytotoxin with a molecular weight < 10 kDa was detected in a single C. concisus strain (RCH 12). A C. concisus genomic library, constructed from strain RCH 3 in Escherichia coli XL1-Blue, was screened for hemolytic clones. Subcloning and sequence analysis of selected hemolytic clones identified ORFs for genes that enhance hemolytic activity but do not appear to be related to any known hemolysin genes found in Gram-negative bacteria. In a previous study, a stable cell-associated hemolysin was identified as an outer-membrane phospholipase A (OMPLA) encoded by the pldA gene. In this study, we report cloning of the pldA gene of the clinical strain C. concisus RCH 3 and the complementation of phospholipase A activity in an E. coli pldA mutant.


Asunto(s)
Campylobacter/genética , Proteínas Hemolisinas/genética , Hemólisis , Fosfolipasas A/genética , Secuencia de Aminoácidos , Proteínas de la Membrana Bacteriana Externa/química , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas de la Membrana Bacteriana Externa/metabolismo , Secuencia de Bases , Campylobacter/aislamiento & purificación , Campylobacter/patogenicidad , Infecciones por Campylobacter/microbiología , Niño , Clonación Molecular , Gastroenteritis/microbiología , Prueba de Complementación Genética , Biblioteca Genómica , Proteínas Hemolisinas/química , Proteínas Hemolisinas/metabolismo , Humanos , Hierro/metabolismo , Datos de Secuencia Molecular , Fosfolipasas A/química , Fosfolipasas A/metabolismo , Fosfolipasas A1/genética , Fosfolipasas A1/metabolismo , Proteínas Recombinantes/metabolismo
15.
Appl Environ Microbiol ; 73(21): 6885-90, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17766455

RESUMEN

A study was conducted to examine the levels of Salmonella spp. contamination in raw food samples, including chicken, beef, pork, and shellfish, from Vietnam and to determine their antibiotic resistance characteristics. A total of 180 samples were collected and examined for the presence of Salmonella spp., yielding 91 Salmonella isolates. Sixty-one percent of meat and 18% of shellfish samples were contaminated with Salmonella spp. Susceptibility of all isolates to a variety of antimicrobial agents was tested, and resistance to tetracycline, ampicillin/amoxicillin, nalidixic acid, sulfafurazole, and streptomycin was found in 40.7%, 22.0%, 18.7%, 16.5%, and 14.3% of the isolates, respectively. Resistance to enrofloxacin, trimethoprim, chloramphenicol, kanamycin, and gentamicin was also detected (8.8 to 2.2%). About half (50.5%) of the isolates were resistant to at least one antibiotic, and multiresistant Salmonella isolates, resistant to at least three different classes of antibiotics, were isolated from all food types. One isolate from chicken (serovar Albany) contained a variant of the Salmonella genomic island 1 antibiotic resistance gene cluster. The results show that antibiotic resistance in Salmonella spp. in raw food samples from Vietnam is significant.


Asunto(s)
Antibacterianos/farmacología , Farmacorresistencia Bacteriana/genética , Contaminación de Alimentos/análisis , Carne/microbiología , Salmonella/efectos de los fármacos , Animales , Farmacorresistencia Microbiana , Microbiología de Alimentos , Productos de la Carne/microbiología , Pruebas de Sensibilidad Microbiana , Salmonella/clasificación , Salmonella/genética , Salmonella/aislamiento & purificación , Vietnam
16.
Microbiology (Reading) ; 152(Pt 5): 1263-1274, 2006 May.
Artículo en Inglés | MEDLINE | ID: mdl-16622044

RESUMEN

Phospholipase A (PLA) is one of the few enzymes present in the outer membrane of Gram-negative bacteria, and is likely to be involved in the membrane disruption processes that occur during host cell invasion. Both secreted and membrane-bound phospholipase A(2) activities have been described in bacteria, fungi and protozoa. Recently there have been increasing reports on the involvement of PLA in bacterial invasion and pathogenesis. This review highlights the latest findings on PLA as a virulence factor in Gram-negative bacteria.


Asunto(s)
Bacterias Gramnegativas/enzimología , Fosfolipasas A/fisiología , Factores de Virulencia/fisiología , Secuencia de Aminoácidos , Membrana Celular/enzimología , Bacterias Gramnegativas/patogenicidad , Datos de Secuencia Molecular , Fosfolipasas A/química , Fosfolipasas A/genética , Factores de Virulencia/química , Factores de Virulencia/genética
17.
Vet Microbiol ; 113(1-2): 109-16, 2006 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-16310325

RESUMEN

A novel outer membrane protein-encoding gene was identified in Brachyspira hyodysenteriae. The predicted protein, SmpB, was encoded by a gene that contains regions of identity with that encoding the previously identified lipoprotein SmpA. However, the majority of the reading frame encoding SmpA and SmpB share no detectable similarity. Analysis of several strains revealed that B. hyodysenteriae harbours either smpA or the newly identified gene smpB, but not both. smpB encodes for a slightly larger protein than smpA, 17.6 and 16.8 kDa, respectively. The predicted proteins share an identical leader sequence and the first 10 amino acids of the mature protein, however, the remainder of the predicted protein sequence shows no similarity. It is hypothesised that smpA and smpB are present on the same area of the chromosome. The proteins are antigenically unique, as antisera raised against a strain of B. hyodysenteriae that expresses SmpA cannot detect SmpB and vice versa. Although the presence of an identical leader peptide suggests identical localisation of SmpA and SmpB, it is not known if the two predicted proteins share similar function.


Asunto(s)
Proteínas de la Membrana Bacteriana Externa/genética , Brachyspira hyodysenteriae/genética , Proteínas de Unión al ARN/genética , Animales , Anticuerpos Antibacterianos/biosíntesis , Anticuerpos Antibacterianos/inmunología , Proteínas de la Membrana Bacteriana Externa/biosíntesis , Proteínas de la Membrana Bacteriana Externa/fisiología , Secuencia de Bases , Southern Blotting/métodos , Brachyspira hyodysenteriae/química , Brachyspira hyodysenteriae/aislamiento & purificación , Brachyspira hyodysenteriae/fisiología , Epítopos , Escherichia coli/genética , Expresión Génica , Immunoblotting/métodos , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa/métodos , Proteínas de Unión al ARN/inmunología , Proteínas de Unión al ARN/fisiología , Conejos , Alineación de Secuencia , Análisis de Secuencia de ADN , Infecciones por Spirochaetales/microbiología , Infecciones por Spirochaetales/veterinaria , Porcinos
18.
J Med Microbiol ; 53(Pt 6): 483-493, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15150326

RESUMEN

A membrane-bound, haemolytic phospholipase A(2) (PLA(2)) activity was detected in clinical strains of Campylobacter concisus isolated from children with gastroenteritis. The clinical strains were assigned into two molecular groups (genomospecies) based on PCR amplification of their 23S rDNA. This calcium-dependent, heat-stable, haemolytic PLA(2) activity was detected in strains from both genomospecies. A crude haemolysin extract (CHE) was initially prepared from cellular outer-membrane proteins of these isolates and was further fractionated by ultrafiltration. The haemolytic activity of the extracted fraction (R30) was retained by ultrafiltration using a 30 kDa molecular mass cut-off filter, and was designated haemolysin extract (HE). Both CHE and HE had PLA(2) activity and caused stable vacuolating and cytolytic effects on Chinese hamster ovary cells in tissue culture. Primers for the conserved region of pldA gene (phospholipase A gene) from Campylobacter coli amplified a gene region of 460 bp in all tested isolates, confirming the presence of a homologous PLA gene sequence in C. concisus. The detection of haemolytic PLA(2) activity in C. concisus indicates the presence of a potential virulence factor in this species and supports the hypothesis that C. concisus is a possible opportunistic pathogen.


Asunto(s)
Campylobacter/enzimología , Proteínas Hemolisinas/análisis , Fosfolipasas A/análisis , Adulto , Animales , Proteínas de la Membrana Bacteriana Externa/análisis , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas de la Membrana Bacteriana Externa/aislamiento & purificación , Células CHO/efectos de los fármacos , Células CHO/patología , Campylobacter/aislamiento & purificación , Campylobacter/patogenicidad , Infecciones por Campylobacter/microbiología , Preescolar , Cricetinae , Inhibidores Enzimáticos/farmacología , Femenino , Gastroenteritis/microbiología , Proteínas Hemolisinas/genética , Proteínas Hemolisinas/aislamiento & purificación , Humanos , Immunoblotting , Lactante , Lípidos/farmacología , Masculino , Fosfolipasas A/genética , Fosfolipasas A/aislamiento & purificación , Especificidad de la Especie , Factores de Virulencia/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA